LW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LW is not a good buy right now for a Beginner with a long-term focus and $50,000-$100,000 to deploy. The stock is showing some short-term technical improvement, but the broader setup is mixed: analyst targets have been cut, sentiment remains cautious, options positioning is bearish, and the most recent news still reflects legal overhang plus lingering fundamental pressure. I would not buy aggressively at this level; hold off until there is clearer confirmation of a durable recovery.
Pre-market price is 43.67, slightly above the reported current price of 43.53 and just below the first resistance at 44.23. MACD histogram is positive and expanding, which is constructive for short-term momentum. RSI at 57.9 is neutral to mildly positive, not overbought. Moving averages are converging, suggesting the trend is still undecided rather than in a strong breakout phase. Key levels: pivot 42.55, support 40.87, resistance 44.23 and 45.28. Overall, the technical picture is mildly bullish in the very near term, but not strong enough to justify a confident long-term buy today.
Stephens initiated coverage with an Equal Weight rating and $46 target, implying the stock may already reflect much of the near-term weakness. Barclays and Wells Fargo still keep Overweight ratings, which supports the possibility of a medium-term recovery. Analysts also noted improving North American execution, moderating capital intensity, rising free cash flow, and activist involvement from Starboard Value as potential supports. The stock’s current price is near support and just under nearby resistance, which leaves room for a short-term bounce if buying interest continues.
Recent analyst commentary has been cautious, with multiple firms lowering price targets. Concerns center on weak restaurant traffic, excess international capacity, soft Europe demand, inflation, currency pressure, and limited visibility into margin recovery. The court partially allowing the securities class action to proceed is another overhang. Historical ERP issues and the prior sales guidance hit still weigh on investor confidence. Pattern-based trend data also suggests weakness over the next week and month.
No usable latest-quarter financial snapshot was provided due to an error, so a detailed quarter-by-quarter review is not available. Based on the analyst notes, the latest quarter appeared to be decent enough to beat estimates and raise guidance modestly, with stronger gross margin and EBITDA trends and better SG&A control. However, the guidance raise was not large enough to convince the market that the recovery is accelerating, and investors remain focused on softer second-half and international pressure. Latest quarter season referenced by analysts: fiscal Q3 2026.
Analyst sentiment is mixed but tilted neutral-to-cautious. Recent targets were lowered by BofA, BNP Paribas, Barclays, Stifel, Wells Fargo, Deutsche Bank, and JPMorgan, showing a broad reduction in expectations. Ratings are clustered around Neutral/Equal Weight/Hold, with a few Overweight ratings still in place from Barclays and Wells Fargo. The pros view is that shares may already discount a lot of the weakness and that North America, free cash flow, and activism could help. The cons view is that international pressure, weak demand, and limited margin visibility keep the recovery case uncertain. Overall Wall Street stance: cautious, not strongly bullish.
